---
document_datetime: 2026-02-24 10:46:59
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ranluspec-epar-all-authorised-presentations_en.pdf
document_name: ranluspec-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.747154
conversion_datetime: 2026-02-25 11:55:13.367172
docling_version:
  docling-serve: 1.13.1
  docling-jobkit: 1.11.0
  docling: 2.74.0
  docling-core: 2.65.2
  docling-ibm-models: 3.11.0
  docling-parse: 5.3.4
  python: cpython-313 (3.13.11)
  plaform: macOS-26.3-arm64-arm-64bit-Mach-O
---
| EMA Number       | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging      | Content (concentration)   | Pack size            |
|------------------|-------------------|------------|------------------------|---------------------------|--------------------------|---------------------------|----------------------|
| EU/1/25/2012/001 | Ranluspec         | 10 mg/ml   | Solution for injection | Intravitreal use          | vial (glass)             | 0.23 ml                   | 1 vial               |
| EU/1/25/2012/002 | Ranluspec         | 10 mg/ml   | Solution for injection | Intravitreal use          | pre-filled syringe (COP) | 0.165 ml                  | 1 pre-filled syringe |